Medherant

Description: Medherant develops TEPI® Patch, a novel transdermal drug delivery system for pain & CNS diseases, leveraging proprietary bioadhesive tech.

Country: UK

Based in: Coventry

Founded: 2015

Funding Stage: Series A/B

Tags: ['Pharmaceuticals', 'CNS diseases', 'eHealth', 'Healthcare']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.